期刊文献+

探讨清肝降脂汤治疗非酒精性脂肪肝的临床疗效 被引量:3

Efficacy of the Qinggan Jiangzhi decoction on nonalcoholic fatty liver
下载PDF
导出
摘要 目的:探讨在治疗非酒精性脂肪肝患者时应用清肝降脂汤的临床疗效。方法:将2015年11月-2017年11月我院临床治疗的84例非酒精性脂肪肝患者随机等分为观察组和对照组。对照组应用常规西药治疗,观察组应用清肝降脂汤治疗,观察比较两组治疗情况。结果:经治疗,观察组治疗的总有效率为95.24%(40/42),高于对照组的73.81%(31/42),且组间数据差异具有统计学意义(P <0.05)。治疗后,观察组B超检总有效率为85.71%(36/42),比对照组的69.05%(29/42)高,且组间数据差异具有统计学意义(P <0.05)。治疗结束后,观察组患者的谷丙转氨酶(ALT)、谷草转氨酶(AST)等肝功能指标及甘油三脂(TG)、总胆固醇(TC)等血脂指标均低于对照组患者,且组间数据差异具有统计学意义(P <0.05)。结论:在非酒精性脂肪肝的治疗中,应用清肝降脂汤的疗效显著,可有效改善患者的临床症状、肝功能及血脂指标。 Objective:To explore the clinical efficacy of the Qinggan Jiangzhi decoction(清肝降脂汤)on non-alcoholic fatty liver.Methods:84 patients with non-alcoholic fatty liver who were treated in our hospital from November 2015 to November 2017 were randomly divided into the observation group and the control group,42 patients in each group.The control group was treated with conventional western medicine,and the observation group was given the Qinggan Jiangzhi decoction.Results:After treatment,the total efficiency was 95.24%(40/42)in the observation group,higher than 73.81%(31/42)in the control group(P<0.05).After treatment,the total efficiency on type-B ultrasonic was 85.71%(36/42)in the observation group,which was higher than 69.05%(29/42)in the control group(P<0.05).Conclusion:The Qinggan Jiangzhi decoction on non-alcoholic fatty liver can effectively improve the clinical symptoms,liver function and blood lipid index.
作者 王彬
出处 《中医临床研究》 2019年第8期59-60,共2页 Clinical Journal Of Chinese Medicine
关键词 清肝降脂汤 非酒精性脂肪肝 临床疗效 The Qinggan Jiangzhi decoction Non-alcoholic fatty liver disease Clinical effects
  • 相关文献

二级参考文献83

  • 1彭勇,徐学义.中医药治疗脂肪肝的研究进展[J].江西中医学院学报,2006,18(1):61-63. 被引量:18
  • 2郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国中医药科技出版社,2000.74.
  • 3李继强.脂肪肝的影像学诊断[M]//范建高,曾民德.脂肪肝.上海:上海医科大学出版社,2000:187-190
  • 4国家中医药管理局.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002.99-104.
  • 5邓铁涛.邓铁涛医集[M].北京:人民卫生出版社,2002.
  • 6Zhou YJ,Li YY,Nie YQ,et al.Natural course of nonal- co-holic fatty liver disease in southern China :A prospee- tivecohort study[J].J Dig Dis, 2012,13 (3) : 153-160.
  • 7GUIDORIZZI DE SIQUEIRA AC, COTRIM HP, ROCHA R,et al. Non alcoholic fatty liver disease and insulin resist- ante= importance of risk factors and histological spectrum [J]. Eur J Gastroenterol Hepatol,2005, 17(8) 837-841.
  • 8BUGIANESI E,LEONE N,VANNI E,et al. Expanding the natural history of nonalcoholic steatohepatitis:from crypto- genic cirrhosis to hepatocelluar carcinoma[J].Gastroenterol- ogy, 2002,123(1):134.
  • 9WONGWANANURUK T,RATTANACHAIYANONT M, INDHAVIVADHANA S, et al. Prevalence and clinical pre- dictors of insulin resistance in reproductive- aged Thai women with polycystic ovary syndrome[J]. Int J Endocri- nol,2012(18) :74-79.
  • 10NOBILI V, ALKHOURI N, ALISI A, et al. Retinol-binding protein4:a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease[J]. Clinical gastro- enterology and hepatology, 2009,7 (5) : 575-579.

共引文献39

同被引文献23

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部